Arbor Rapha Capital Bioholdings Corp. I (ARCKU) Stock Analysis

What Arbor Rapha Capital Bioholdings Corp. I does

Arbor Rapha Capital Bioholdings Corp. I currently possesses no substantial business operations. Its primary objective is to execute a strategic business combination, which could involve a merger, stock exchange, asset or stock acquisition, or reorganization, with one or more entities. The firm specifically seeks to identify potential acquisition targets within the biopharmaceutical industry. Established in 2021, the company is headquartered in Uniondale, New York.

Key metrics

ETFs linked to ARCKU

Broad-market and Financial Services sector ETFs an investor holding Arbor Rapha Capital Bioholdings Corp. I is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ARCKU fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Frequently asked questions

What is the ticker symbol for Arbor Rapha Capital Bioholdings Corp. I?

Arbor Rapha Capital Bioholdings Corp. I trades under the ticker ARCKU on NASDAQ.

Which exchange is ARCKU listed on?

ARCKU is listed on NASDAQ.

What sector does Arbor Rapha Capital Bioholdings Corp. I operate in?

Arbor Rapha Capital Bioholdings Corp. I is classified in the Financial Services sector (Shell Companies industry).

How can PortView help analyze ARCKU in a portfolio?

PortView shows ARCKU's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.